Suppr超能文献

日本普拉德-威利综合征患者糖尿病的特征分析

Characterization of diabetes mellitus in Japanese prader-willi syndrome.

作者信息

Tsuchiya Takayoshi, Oto Yuji, Ayabe Tadayuki, Obata Kazuo, Murakami Nobuyuki, Nagai Toshiro

机构信息

Department of Pediatrics, Dokkyo Medical University Koshigaya Hospital, Saitama, Japan.

出版信息

Clin Pediatr Endocrinol. 2011 Apr;20(2):33-8. doi: 10.1297/cpe.20.33. Epub 2011 Oct 7.

Abstract

Prader-Willi syndrome (PWS) is frequently associated with marked obesity and diabetes mellitus (DM). Although the overall frequency of DM in PWS ranges from 7-20%, there is only limited data available on Japanese patients. This study evaluated five factors associated with DM in PWS: 1) frequency, 2) age of onset, 3) risk factors, 4) long-term complications and 5) treatment. Sixty-five patients, ranging in age from 10 to 53 yr, were studied retrospectively. The frequency of DM in patients over 10 yr of age was 26.2% (17/65 patients). The age of DM onset ranged from 10 to 29 yr with a median age of 15 yr. The body mass index (BMI) was significantly higher in the DM group in comparison with the non-DM group. The number of patients using growth hormone (GH) in the DM group was significantly lower than the number that did not. Proteinuria (urinary excretion of albumin/creatinine at spot collection: U-Alb/Cr ≥300 mg/gCr) was observed in 1/17 patients (5.9%), microalbuminuria (U-Alb/Cr 30-300 mg/gCr) was observed in 4/17 patients (23.5%) and nonproliferative retinopathy was observed in 2/17 patients (11.8%). Among oral hypoglycemic agents, alpha-glucosidase inhibitors (α-GI) were most often used in our patients (10/17, 58.8%). Eleven out of 17 patients (64.7%) had been treated with insulin.

摘要

普拉德-威利综合征(PWS)常伴有明显肥胖和糖尿病(DM)。尽管PWS中DM的总体发生率为7%-20%,但关于日本患者的数据有限。本研究评估了与PWS中DM相关的五个因素:1)发生率,2)发病年龄,3)危险因素,4)长期并发症和5)治疗。对65例年龄在10至53岁之间的患者进行了回顾性研究。10岁以上患者的DM发生率为26.2%(17/65例患者)。DM发病年龄为10至29岁,中位年龄为15岁。与非DM组相比,DM组的体重指数(BMI)显著更高。DM组使用生长激素(GH)的患者数量明显低于未使用的患者数量。1/17例患者(5.9%)出现蛋白尿(即时尿白蛋白/肌酐排泄率:U-Alb/Cr≥300mg/gCr),4/17例患者(23.5%)出现微量白蛋白尿(U-Alb/Cr 30-300mg/gCr),2/17例患者(11.8%)出现非增殖性视网膜病变。在口服降糖药中,α-葡萄糖苷酶抑制剂(α-GI)在我们的患者中使用最为频繁(10/17,58.8%)。17例患者中有11例(64.7%)接受了胰岛素治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f9b/3687633/5ec1c195e292/cpe-20-033-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验